Hantavirus: Britain secures experimental Japanese drug to strengthen response
Published on: May 19, 2026, 11:17 a.m. | Source: The Economic Times
Britain has received experimental favipiravir from Japan to treat a deadly hantavirus outbreak. The drug is not licensed in the UK and its use for hantavirus is experimental. The outbreak involves Andes virus, which can spread between people. Health officials confirm no increased transmissibility or pandemic risk.
